Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Regular physical activity may improve well-being of African American cancer survivors

New research suggests that regular exercise may improve the well-being of African American cancer survivors, but most survivors do not meet current recommendations for physical activity.

25 Feb 2020

Hormone blocker shocker: Drug costs 8 times more when used for kids

Dr. Sudeep Taksali, an orthopedic surgeon, became worried that his 8-year-old daughter had already grown taller than his 12-year-old son. And sometimes she had an attitude more befitting a teenager. Something seemed wrong.

24 Feb 2020

Lengthening prostate cancer screening intervals for men could improve outcomes

A new study in JNCI: Journal of the National Cancer Institute, published by Oxford University Press, finds significant benefits to lengthening the amount of time between prostate cancer screenings for men.

18 Feb 2020

Study provides insight into link between cancer driver gene and alternative splicing changes

A multi-institutional group of researchers led by Children's Hospital of Philadelphia has linked a strong cancer driver gene to changes in proteins that regulate alternative splicing.

17 Feb 2020

A high number of lifetime sexual partners raises cancer risk

A new study seems to reinforce traditional common sense and good morals: people who play around with sex tend to have a higher risk of cancer. The study published online in the journal BMJ Sexual and Reproductive Health in February 2020 shows that having ten or more sex partners increases the risk of cancer in both men and women. And in women, this pattern of sexual behavior increases the chances of a chronic debilitating illness.

13 Feb 2020

Moffitt research may provide a path toward improved multi-drug adaptive therapies

Personalized cancer treatments have greatly improved the lives of patients; however, many eventually develop resistance to these targeted drugs.

13 Feb 2020

High testosterone in women ups risk for cancer, diabetes, and metabolic disease

Testosterone is a steroid hormone that triggers the development of male secondary sex characteristics. Though found mainly in men, the ovaries in women release small amounts of testosterone. When combined with estrogen, testosterone aids in the growth and repair of a woman's reproductive tissues.

12 Feb 2020

Study: Most men choosing surgery for prostate cancer do not regret their decisions

Men with localized prostate cancer are faced with deciding among a range of options for treatment - including a choice between robot-assisted versus conventional prostatectomy.

10 Feb 2020

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Among high-risk prostate cancer patients - those with high PSA and Gleason scores of 8 or more - many will develop a difficult-to-treat disease.

10 Feb 2020

Largest genome study sheds light on how genetic glitches trigger tumor formation

It is well-known that when a gene mutates, it triggers tumor formation by stimulating abnormal cell growth and proliferation. Cancer starts from a mutant gene that kickstarts a series of abnormal growth, forming a tumor. However, the exact mechanism of how this happens remains unclear.

6 Feb 2020

Cedars-Sinai researchers to study role of fat in promoting cancer spread to liver

A diagnosis of pancreatic or colon cancer often sparks dread about the disease's likely next destination: the liver. That's because liver metastasis is a leading cause of death in these patients.

6 Feb 2020

Researchers compile large catalog of cancer mutations

Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet.

6 Feb 2020

Cancer deaths down by 29 percent over last two decades

The American Cancer Society reports that cancer deaths in the United States have decreased by as much as 29 percent between 1991 and 2017, thanks to early detection and treatment advances.

5 Feb 2020

Research highlights the benefits of physical activity for older adults

Physically active older adults benefit from reduced risks of early death, breast and prostate cancer, fractures, recurrent falls, functional limitations, cognitive decline, dementia, Alzheimer's disease, and depression.

5 Feb 2020

Practo Insights: Appointments with oncologists increase by 94% in India

Cancer cases in India have doubled in recent years. According to reports, India’s cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.

4 Feb 2020

Researchers develop an emergency stop switch for CAR T-cell therapies

Immunotherapy, unlike chemotherapy and radiotherapy, arms the body's immune system to attack cancer cells. In recent years, it has proven to be remarkably successful at treating leukemia, lymphoma and other liquid cancers, or cancers present in body fluids.

4 Feb 2020

Ludwig Cancer Research study develops a safer CAR-T therapy

A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell - a family of promising immunotherapies for cancer- that can be switched on and off on demand.

3 Feb 2020

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.

3 Feb 2020

Comparing DNA-repair gene mutations in African American and Caucasian men with prostate cancer

Pathogenic or likely pathogenic alterations in these 14 DNA repair genes were less likely to be detected in African Americans as compared to Caucasians.

3 Feb 2020

Novel inhibitor to fight metastatic prostate cancer shows promise

When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.

30 Jan 2020

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Regular physical activity may improve well-being of African American cancer survivors

Hormone blocker shocker: Drug costs 8 times more when used for kids

Lengthening prostate cancer screening intervals for men could improve outcomes

Study provides insight into link between cancer driver gene and alternative splicing changes

A high number of lifetime sexual partners raises cancer risk

Moffitt research may provide a path toward improved multi-drug adaptive therapies

High testosterone in women ups risk for cancer, diabetes, and metabolic disease

Study: Most men choosing surgery for prostate cancer do not regret their decisions

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Largest genome study sheds light on how genetic glitches trigger tumor formation

Cedars-Sinai researchers to study role of fat in promoting cancer spread to liver

Researchers compile large catalog of cancer mutations

Cancer deaths down by 29 percent over last two decades

Research highlights the benefits of physical activity for older adults

Practo Insights: Appointments with oncologists increase by 94% in India

Researchers develop an emergency stop switch for CAR T-cell therapies

Ludwig Cancer Research study develops a safer CAR-T therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Comparing DNA-repair gene mutations in African American and Caucasian men with prostate cancer

Novel inhibitor to fight metastatic prostate cancer shows promise

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in